Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd./ JP3463000004 /
TKPHF
|
2024-05-09 4:11:21 PM
|
Chg.
-
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
26.8300USD
|
-
|
814
Turnover: 2,683 |
-Bid Size: - |
-Ask Size: - |
41.94 bill.USD |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
204.29 JPY |
38.84% |
| EPS Diluted: |
- JPY |
38.44% |
| Revenues per Share: |
2,545.34 JPY |
12.84% |
| Book Value per Share: |
4,015.76 JPY |
11.81% |
| Cash Flow per Share: |
617.56 JPY |
-13.00% |
| Dividend per Share: |
180.00 JPY |
0.00% |
| Total |
in mill. |
|
| Revenues: |
4,027,478.00 JPY |
12.85% |
| Net Income: |
317,017.00 JPY |
37.80% |
| Operating Cash Flow: |
977,156.00 JPY |
- |
| Cash and Cash Equivalents: |
533,530.00 JPY |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
20.21 |
21.29 |
| P/S Ratio: |
1.62 |
1.71 |
| P/BV ratio: |
1.03 |
1.08 |
| P/CF Ratio: |
6.69 |
7.04 |
| PEG: |
0.52 |
0.55 |
| Earnings Yield: |
4.95% |
4.70% |
| Dividend Yield: |
4.36% |
4.14% |
| Market Capitalization |
|
| Market Capitalization: |
41.94 bill. USD |
48.82 bill. USD |
| Free Float Market Cap.: |
- USD |
- USD |
| Market Cap. / Employee: |
885,742.5929 USD |
1.03 mill. USD |
| Shares Outstanding: |
1.58 bill. |
|
Profitability
| Gross Profit Margin: |
69.11% |
| EBIT Margin: |
12.18% |
| Net Profit Margin: |
7.87% |
| Return on Equity: |
4.99% |
| Return on Assets: |
2.27% |
Financial Strength
| Liquidity I / Cash Ratio: |
21.50% |
| Liquidity II / Quick Ratio: |
47.66% |
| Liquidity III / Current Ratio: |
96.62% |
| Debt / Equity Ratio: |
119.66% |
| Dynam. Debt / Equity Ratio: |
778.14% |
Efficiency
| Employees: |
47,347 |
| Personal Expenses / Employee: |
- JPY |
| Revenues / Employee: |
85,063,002.94 JPY |
| Net Income / Employee: |
6,695,609.01 JPY |
| Total Assets / Employee: |
294,796,924.83 JPY |
| * Fiscal Year End: |
2023-03-31 |
| Accounting Standard: |
IFRS |
